Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The slow activity-associated genotype of microsomal epoxide hydroxylase-1 (m-EPHX-1) and low serum paraoxonase-1 (PON1) activity are associated with increased susceptibility to chronic obstructive pulmonary disease (COPD) in smokers

The slow activity-associated genotype of microsomal epoxide hydroxylase-1 (m-EPHX-1) and low... Oxidative stress is believed to play an important role in the pathogenesis of smoking-induced chronic obstructive pulmonary disease (COPD). We hypothesized that low serum activity level of paraoxonase-1 (PON1) that play a protective role in the lungs by metabolizing lipid peroxides and genetic polymorphism of antioxidant enzymes that detoxify cigarette smoke products such as microsomal epoxide hydroxylase-1 (m-EPHX-1) would be associated with increased susceptibility to COPD in smokers. The study was conducted on patients admitted to Chest Diseases Department, Kasr Al-Aini Hospital, Cairo University. Sixty subjects were divided into three groups—25 COPD patients, 25 chronic smokers without COPD, and 10 healthy nonsmokers. Pulmonary function tests were done for confirmation of COPD. Serum PON1 activity assay using spectrophotometric kinetic method and PCR-RFLP for genetic polymorphism of m-EPHX-1 exon 3 113 T>C were done to all participants. The significantly low median value for serum PON1 activity was found in COPD and smoker groups compared to the nonsmoker group (P = 0.015). Homozygote mutant genotype (HH) of m-EPHX-1 was present only in the COPD group compared to the other two groups with a frequency of 20%, 0%, and 0% respectively [P = 0.013; odds ratio (OR), 4.26; P = 0.008]. The OR between COPD and nonsmoker group was 14.222 (P = 0.008). The frequency of TH genotype was highest in the COPD group (44%, P = 0.013). While the wild genotype (TT) was more frequent in the nonsmoker group compared to the smokers and COPD groups (80%, 64%, and 36% respectively; P = 0.013). The slow m-EPHX-1 exon 3 polymorphisms (HH and HT) and the reduced serum PON1 activity are associated with higher susceptibility to COPD in smokers. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Comparative Clinical Pathology Springer Journals

The slow activity-associated genotype of microsomal epoxide hydroxylase-1 (m-EPHX-1) and low serum paraoxonase-1 (PON1) activity are associated with increased susceptibility to chronic obstructive pulmonary disease (COPD) in smokers

Download PDF
7 pages

Loading next page...
 
/lp/springer-journals/the-slow-activity-associated-genotype-of-microsomal-epoxide-YsZ0T0X2Np
Publisher
Springer Journals
Copyright
Copyright © 2012 by Springer-Verlag London Limited
Subject
Medicine & Public Health; Pathology; Hematology; Oncology
eISSN
1618-565X
DOI
10.1007/s00580-012-1416-7
Publisher site
See Article on Publisher Site

Abstract

Oxidative stress is believed to play an important role in the pathogenesis of smoking-induced chronic obstructive pulmonary disease (COPD). We hypothesized that low serum activity level of paraoxonase-1 (PON1) that play a protective role in the lungs by metabolizing lipid peroxides and genetic polymorphism of antioxidant enzymes that detoxify cigarette smoke products such as microsomal epoxide hydroxylase-1 (m-EPHX-1) would be associated with increased susceptibility to COPD in smokers. The study was conducted on patients admitted to Chest Diseases Department, Kasr Al-Aini Hospital, Cairo University. Sixty subjects were divided into three groups—25 COPD patients, 25 chronic smokers without COPD, and 10 healthy nonsmokers. Pulmonary function tests were done for confirmation of COPD. Serum PON1 activity assay using spectrophotometric kinetic method and PCR-RFLP for genetic polymorphism of m-EPHX-1 exon 3 113 T>C were done to all participants. The significantly low median value for serum PON1 activity was found in COPD and smoker groups compared to the nonsmoker group (P = 0.015). Homozygote mutant genotype (HH) of m-EPHX-1 was present only in the COPD group compared to the other two groups with a frequency of 20%, 0%, and 0% respectively [P = 0.013; odds ratio (OR), 4.26; P = 0.008]. The OR between COPD and nonsmoker group was 14.222 (P = 0.008). The frequency of TH genotype was highest in the COPD group (44%, P = 0.013). While the wild genotype (TT) was more frequent in the nonsmoker group compared to the smokers and COPD groups (80%, 64%, and 36% respectively; P = 0.013). The slow m-EPHX-1 exon 3 polymorphisms (HH and HT) and the reduced serum PON1 activity are associated with higher susceptibility to COPD in smokers.

Journal

Comparative Clinical Pathology – Springer Journals

Published: Jan 28, 2012

References

  • Guidelines for the management of chronic obstructive pulmonary disease
  • Genetic association between COPD and polymorphisms in TNF, ADRB2 and mEPHX
    Brogger, J; Steen, VM; Eiken, HG; Gulsvik, A; Bakke, P
  • Accuracy and biological variation of human serum PON1 activity by enzymatic enzyme assay
    Browne, RW; Koury, ST; Marion, ST; Wilding, G
  • Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD
    Chappell, S; Daly, L; Morgan, K; Guetta-Baranes, T; Roca, J; Rabinovich, R; Lotya, J; Millar, AB; Donnelly, SC; Keatngs, V
  • Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD
    Cheng, SL; Yu, CJ; Chen, CJ
  • Oxidants antioxidants and respiratory tract lining fluids
    Cross, CE; Vliet, A; O’Neill, CA
  • Review: paraoxonase and atherosclerosis
    Durrington, PN; Mackness, B; Mackness, MI
  • Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases
    Ferré, N; Marsillach, J; Camps, J; Mackness, B; Mackness, M; Riu, F; Coll, B; Tous, M; Joven, J
  • Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants
    Hassett, C; Aicher, L; Sidhu, JS; Omiecinski, CJ
  • Genetic association analysis of functional impairment in chronic obstructive pulmonary disease
    Hersh, CP; Demeo, DL; Lazarus, R; Celedón, JC; Raby, BA; Benditt, JO; Criner, G; Make, B; Martinez, FJ; Scanlon, PD; Sciurba, FC; Utz, JP; Reilly, JJ; Silverman, EK
  • Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery
    Hersh, CP; DeMeo, DL; Reilly, JJ; Silverman, EK
  • Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses
    Hu, G; Shi, Z; Hu, J; Zou, G; Peng, G; Ran, P
  • Trace elements and oxidative stress in COPD
    Isik, B; Isik, RS; Ceylan, A; Calik, O
  • A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure
    Jindal, SK; Aggarwal, AN; Chaudhry, K; Chhabra, SK; D’Souza, GA; Gupta, D; Katiyar, SK; Kumar, R; Shah, B; Vijayan, VK
  • EPHX1 polymorphisms and the risk of lung cancer: a huge review
    Kiyohara, C; Yoshimaso, K; Takayama, K; Nakanishi, Y
  • Global and regional burden of disease and risk factors: systematic analysis of population health data
    Lopez, AD; Mathers, CD; Ezzati, M
  • Paraoxonase and coronary heart disease
    Mackness, MI; Mackness, B; Durrington, PN; Fogelman, AM; Berliner, J; Lusis, AJ; Navab, M; Shih, D; Fonarow, GC
  • Diagnosis and treatment of patients with COPD
    MacNee, W; Celli, BR
  • A simple salting out procedure for extraction of dna from human nucleated cells
    Miller, SA; Dykes, DD; Polesky, HH
  • Cigarette smoke extracts inhibit plasma PON1 activity by modification of the enzyme’s free thiols
    Nisho, E; Wanatobe, Y
  • Analysis of association between PPAR gamma and EPHX1polymorphisms and susceptibility to COPD in a Hungarian cohort, a case–control study
    Penyige, A; Poliska, S; Csanky, E; Scholtz, B; Dezso, B; Schmellczer, I; Kilty, L; Takacs, L; Nagy, L
  • Role of oxidants/antioxidants in lung disease
    Pryor, WA; Stone, K
  • Antioxidants therapiotic advances
    Rahman, I
  • Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in type II diabetes
    Sampson, MJ; Braschi, S; Willis, G; Astley, SB
  • Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
    Smith, CAD; Harrison, DJ
  • Susceptibility genes for rapid decline of lung function in the lung health study
    Stanford, AJ; Chagani, T; Weir, TD; Connett, JE; Anthonisen, NR; Pare, PD
  • COPD and PON1 192 and 55 gene polymorphisms
    Tekes, S; Isik, B; Yildiz, T; Simsek, S; Isik, MR; Budak, T
  • Interaction between Gln-Arg 192 variants of PON1 gene and oleic acid intake as determinant of HDL and PON1 activity
    Tomas, M; Senti, M; Elosua, R; Sala, J; Masia, R
  • Respiratory symptoms and cotton dust exposure; results of a 15 year follow up observation
    Wang, XR; Eisen, EA; Zhang, HX; Sun, BX; Dai, HL; Pan, LD; Wegman, DH; Olenchock, SA; Christiani, DC
  • Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population
    Židzik, J; Slabá, E; Joppa, P; Kluchová, Z; Dorková, Z; Skyba, P; Habalová, V; Šalagovič, J; Tkáčová, R